Ignite Creation Date:
2024-05-06 @ 6:06 PM
Last Modification Date:
2024-10-26 @ 2:41 PM
Study NCT ID:
NCT05546580
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2022-09-15
Brief Title:
Study of Iadademstat and Gilteritinib in Patients With RR AML With FMS-like Tyrosine Kinase Mutation FLT3 Mut
Sponsor:
Oryzon Genomics SA
Organization:
Oryzon Genomics SA
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Myeloid Leukemia Refractory |
| Acute Myeloid Leukemia in Relapse |
Keywords:
| Name | View |
|---|---|
| Acute Myeloid Leukemia FLT3 mut | View |